Significant Ownership of SAIF Partners IV L.P.
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for SAIF Partners IV L.P. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager location
- Hong Kong, Hong Kong
- Manager signature
- /s/Andrew Y Yan - Director of SAIF IV GP Capital Ltd., which is the General Partner of SAIF IV GP, L.P., which is the General Partner of SAIF Partners IV L.P.
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow SAIF Partners IV L.P. with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from SAIF Partners IV L.P.
Significant Ownership of SAIF Partners IV L.P.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SVA | SINOVAC BIOTECH LTD. | Common Shares, par value US$0.001 per share | 15% | 10,780,820 | 0% | SAIF Partners IV L.P. | 15 Dec 2025 | ||
| AMPX | Amprius Technologies, Inc. | Common Stock, $0.0001 par value per share | 0% | $0 | -$48,998,978 | 0 | -100% | SAIF Partners IV L.P. | 30 Jun 2025 |
Schedules 13D/G Reported by SAIF Partners IV L.P.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.